Baricitinib is an immunomodulator used to treat rheumatoid arthritis and COVID-19. It works by inhibiting viral entry and reducing inflammation. Baricitinib is effective in managing autoimmune diseases and viral infections. In summary, Baricitinib is vital for treating inflammatory conditions and COVID-19.
Baricitinib inhibits Janus kinase (JAK) pathways, reducing cytokine signaling and inflammatory responses.